Eli Lilly (LLY) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to -$7.3 billion.
- Eli Lilly's Enterprise Value fell 11739.0% to -$7.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$7.3 billion, marking a year-over-year decrease of 11739.0%. This contributed to the annual value of -$7.3 billion for FY2025, which is 11739.0% down from last year.
- Per Eli Lilly's latest filing, its Enterprise Value stood at -$7.3 billion for Q4 2025, which was down 11739.0% from -$9.9 billion recorded in Q3 2025.
- In the past 5 years, Eli Lilly's Enterprise Value registered a high of -$2.1 billion during Q4 2022, and its lowest value of -$9.9 billion during Q3 2025.
- Moreover, its 5-year median value for Enterprise Value was -$3.1 billion (2021), whereas its average is -$3.5 billion.
- In the last 5 years, Eli Lilly's Enterprise Value soared by 4411.47% in 2022 and then crashed by 18670.33% in 2025.
- Quarter analysis of 5 years shows Eli Lilly's Enterprise Value stood at -$3.7 billion in 2021, then skyrocketed by 44.11% to -$2.1 billion in 2022, then plummeted by 35.94% to -$2.8 billion in 2023, then dropped by 17.89% to -$3.3 billion in 2024, then plummeted by 117.39% to -$7.3 billion in 2025.
- Its Enterprise Value stands at -$7.3 billion for Q4 2025, versus -$9.9 billion for Q3 2025 and -$3.5 billion for Q2 2025.